QIAGEN Releases New Pandemic Influenza A/H1N1 Detection Kit
Advertisement
QIAGEN announced both the launch of a new Influenza A/H1N1 test and several updates to its activities in providing solutions for the global surveillance of the swine flu pandemic. QIAGEN’s new kit enables both the highly sensitive and specific detection of the novel Influenza A/H1N1, the virus that causes “swine flu”, as well as of all other known Influenza A and B virus strains. The new test kit has been designed for use by governments and public health institutions as part of the efforts to identify and control outbreaks of pandemic A/H1N1 Influenza.
“With QIAGEN’s new test and our existing solutions to support Tamiflu/Oseltamivir resistance testing, we offer healthcare professionals powerful tools not only to quickly and reliably detect the origin of flu-like symptoms in patients, but also to profile the pathogen and thus to rapidly take the necessary actions to control an outbreak,” said Peer Schatz, CEO of QIAGEN. “In the light of the upcoming flu season and the likely emergence and dissemination of other Influenza A and B strains, these capabilities are vital to effectively fight the further dissemination and the effects of the H1N1 pandemic.”
Other news from the department research and development
Most read news
More news from our other portals
Last viewed contents
Antihypertensive drugs may protect against Alzheimer's disease - Drugs may promote memory function and reduce cognitive deterioration without influencing blood pressure
SEQUENOM and National Institutes of Health Expand Relationship for Gene Expression - Agreement Builds on Success of Previous SNP Genotyping Research
Muscle-Targeted Gene Therapy Reverses Rare Muscular Dystrophy in Mice
Study finds 'mad cow disease' in cattle can spread widely in ANS before detectable in CNS
Simple and Fast Method for Radiolabelling Antibodies against Breast Cancer - Using UV light, radiolabelled antibodies can be produced in just 15 minutes
Bioactive natural compounds for the fight against cancer - New synthesis route manages without toxic and expensive oxidizing agent and at the same time proves to be much more efficient
Genzyme Receives Approval for Additional Manufacturing at Ireland Plant - Thymoglobulin Fill/Finishing to Begin Immediately
A fruit a day may keep Alzheimer's at bay, suggests new Cornell study
Ear wax as a possible screening medium for Parkinson’s disease
BASF invests in biotechnology start-up Bota Bio - Bota Bio’s next-generation industrial biology platform is a combination of computation and cutting-edge biotechnology
